Dydrogesteronum [INN-Latin] en es it fr

Dydrogesteronum [INN-Latin] Brand names, Dydrogesteronum [INN-Latin] Analogs

Dydrogesteronum [INN-Latin] Brand Names Mixture

  • No information avaliable

Dydrogesteronum [INN-Latin] Chemical_Formula


Dydrogesteronum [INN-Latin] RX_link


Dydrogesteronum [INN-Latin] fda sheet

Dydrogesteronum_[INN-Latin] FDA

Dydrogesteronum [INN-Latin] msds (material safety sheet)

Dydrogesteronum [INN-Latin] Synthesis Reference

No information avaliable

Dydrogesteronum [INN-Latin] Molecular Weight

302.415 g/mol

Dydrogesteronum [INN-Latin] Melting Point

No information avaliable

Dydrogesteronum [INN-Latin] H2O Solubility

Soluble (difumarate formulation)

Dydrogesteronum [INN-Latin] State


Dydrogesteronum [INN-Latin] LogP


Dydrogesteronum [INN-Latin] Dosage Forms

Opthalmic solution (0.05%)

Dydrogesteronum [INN-Latin] Indication

For the temporary relief of the signs and symptoms of allergic conjunctivitis.

Dydrogesteronum [INN-Latin] Pharmacology

Emedastine is a relatively selective H1-receptor antagonist.

Dydrogesteronum [INN-Latin] Absorption

Ophthalmic use of emedastine usually does not produce measurable plasma concentrations.

Dydrogesteronum [INN-Latin] side effects and Toxicity

Somnolence and malaise have been reported following daily oral administration.

Dydrogesteronum [INN-Latin] Patient Information

Dydrogesteronum [INN-Latin] Organisms Affected

Humans and other mammals